Elevated podoplanin expression within the tumor microenvironment may result in the local sequestration of CLEC-2, either via stable ligand-receptor binding or receptor internalization at the tumor-platelet interface, ultimately decreasing the levels of free, circulating CLEC-2 detectable in plasma. Here, CLEC1B is linked to neoplasm.